Sign In
Buy DXCM
$86.94
-0.370 (-0.424%)
At Close: Aug 04, 2026
Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook
07:30am, Monday, 13'th Jan 2025
SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook.
3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025
08:30am, Wednesday, 08'th Jan 2025
The past year was a great one for the stock market as a whole, but there were plenty of companies that didn't do well in 2024. Shares of Celsius Holdings (CELH 0.93%), DexCom (DXCM -0.66%), and Nike (
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024
07:45am, Saturday, 04'th Jan 2025
Now that we've shut the door on 2024, it's useful to look back at some of the best -- and, on the flip side, some of the worst -- performers of the year on the stock market. Many outliers were in the
Abbott and DexCom settle glucose monitor patent disputes
04:17pm, Monday, 23'rd Dec 2024
Abbott Laboratories said on Monday it and DexCom have reached an agreement to settle all patent disputes between the companies related to continuous glucose monitoring devices.
DexCom (DXCM) Soars 5.6%: Is Further Upside Left in the Stock?
07:31am, Monday, 23'rd Dec 2024
DexCom (DXCM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the
1 Reason to Sell DexCom Stock, and 1 Reason to Buy
06:45am, Saturday, 21'st Dec 2024
Shares of the medical-device maker DexCom (DXCM 5.57%) are down by 37% this year. The diabetes-focused healthcare company disappointed investors with its second-quarter results, leading to a massive d
2025 Picks: 2 Stocks to Buy Now for 50% Upside
09:01am, Friday, 20'th Dec 2024
Two S&P 500 stocks--DexCom and Albemarle--are already on sale for investors to buy in 2025.
Diabetes Brands Dexcom, Ozempic, Mounjaro Drive Q3 Convergent TV Ad Engagement
08:30am, Thursday, 19'th Dec 2024
NEW YORK--(BUSINESS WIRE)--EDO, the TV outcomes company, has released its Q3 2024 Diabetes Convergent TV Outcomes Report, providing critical insights into the diabetes category linear and streaming TV
DXCM Stock Gains on the Launch of Proprietary Generative AI Platform
11:35am, Wednesday, 18'th Dec 2024
Dexcom announces the first Generative AI platform in glucose biosensing.
Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels
09:00am, Tuesday, 17'th Dec 2024
Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI pla
Dexcom Launches the First Generative AI Platform in Glucose Biosensing
09:00am, Tuesday, 17'th Dec 2024
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today it has launched a proprietary Generative AI (GenAI) platform, making Dexcom the first C
BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing technology, is proud to announce that the Dexcom G7 Continuous Glucose Monitoring (CGM) S
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
09:01am, Friday, 13'th Dec 2024
DXCM continues to raise optimism among investors owing to its strong product portfolio.
DexCom: Brighter 2025 From Stelo Ramp
03:18pm, Tuesday, 10'th Dec 2024
DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors remains strong. Q3 revenue grew only 2% y/y to $994.2 million, with temporary
11 Ultra SWAN Bargains That Could Thrive As The Market Soars To Record Highs
07:00am, Thursday, 05'th Dec 2024
The S&P is up 27% in 2024, including a 5.5% rally in November. The Euphoria index is at record highs, indicating investor sentiment is extremely bullish. While 2025 is likely to see much larger volati
